<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="publisher-id">PAMJ</journal-id>
      <journal-title-group>
        <journal-title>The Pan African Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1937-8688</issn>
      <publisher>
        <publisher-name>The African Field Epidemiology Network</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25883722</article-id>
      <article-id pub-id-type="pmc">4393957</article-id>
      <article-id pub-id-type="publisher-id">PAMJ-19-294</article-id>
      <article-id pub-id-type="doi">10.11604/pamj.2014.19.294.2973</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Apocrine carcinoma of the male breast: a case report of an exceptional tumor</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sekal</surname>
            <given-names>Mohammed</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="corresp" rid="cor1">&amp;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Znati</surname>
            <given-names>Kaoutar</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harmouch</surname>
            <given-names>Taoufiq</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Riffi</surname>
            <given-names>Afaf Amarti</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
      </contrib-group>
      <aff id="AF0001"><label>1</label>Department of Pathology, University Hospital Hassan II of Fez, Morocco</aff>
      <author-notes>
        <corresp id="cor1"><label>&amp;</label>Corresponding author: Mohammed Sekal, Department of Pathology, University Hospital Hassan II of Fez, Morocco</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>19</volume>
      <elocation-id>294</elocation-id>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>6</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>4</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Mohammed Sekal et al.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Apocrine carcinoma of the male breast is an exceptional malignant tumor. It does not have a particular clinical or radiological appearance, but it's microscopically characterized by the presence of granular cells and foamy cells representing over 90% of tumor cells. These cells express most of the time the GCDFP-15 and the androgen receptors. This tumor is a distinct molecular entity. In this observation, we report the case of a 70 year old man presenting apocrine carcinoma of the left breast diagnosed at the stage of lung metastasis.</p>
      </abstract>
      <kwd-group>
        <kwd>Apocrine carcinoma</kwd>
        <kwd>breast</kwd>
        <kwd>man</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S0001">
      <title>Introduction</title>
      <p>Apocrine carcinoma of the breast is a malignant tumor, microscopically characterized by the presence of granular cells and foamy cells representing over 90% of tumor cells. It does not have a particular clinical or radiological appearance, but it's a distinct molecular entity. We report an exceptional observation of apocrine carcinoma of breast in a man.</p>
    </sec>
    <sec id="S0002">
      <title>Patient and observation</title>
      <p>He's a 70 years old man who had for 9 years ago a painless nodule at the left breast. It was movable relative to superficial and deep plans. Then, this nodule presented a rapid augmentation of its volume with adhesion to both superficial and deep plans, and inflammatory opposite signs. Mammography showed an ACR5 lesion measuring 4 cm long axis. We realized a fine-needle aspiration cytology, a spread on slides and stained with May-Gr&#xFC;nwald Giemsa (MGG) which showed isolated carcinomatous cells, sometimes forming three-dimensional clusters. Their nucleus is large and irregular with nucleolus. The cytoplasm is abundant. We did not observe myoepithelial cells and the background is necrotic and hemorrhagic (<xref ref-type="fig" rid="F0001">Figure 1</xref>). A biopsy of the tumor was performed. It objectified after Hematoxylin Eosin saffron Staining (HES) staining, a carcinomatous proliferation forming clusters and cellular cords. The tumor cells showed a large and irregular nucleus with prominent nucleoli and abundant cytoplasm, sometimes eosinophilic and granular, and sometimes micro-vesicular. Cytoplasmic borders are clear (<xref ref-type="fig" rid="F0002">Figure 2</xref>, <xref ref-type="fig" rid="F0003">Figure 3</xref>). The number of mitoses was estimated at 7 per 10 fields. An immunohistochemical study showed that tumor cells express GCDFP-15 (<xref ref-type="fig" rid="F0004">Figure 4</xref>), but do not express estrogenic and progesterone receptors, nor Her 2. The diagnosis of apocrine carcinoma of the breast is made. The staging has objectified the presence of lung metastases. The patient received palliative chemotherapy. He died after 8 months of evolution.</p>
      <fig id="F0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>MGG stained cytology after a fine needle aspiration showing isolated apocrine cells with a large irregular nucleus, and abundant cytoplasm. The background is hemorrhagic</p>
        </caption>
        <graphic xlink:href="PAMJ-19-294-g001"/>
      </fig>
      <fig id="F0002" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Carcinomatous proliferation forming clusters of cells with a large irregular nucleus, a prominent nucleoli and clear cytoplasmic borders (HES x100)</p>
        </caption>
        <graphic xlink:href="PAMJ-19-294-g002"/>
      </fig>
      <fig id="F0003" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Type A cells are distinguished with abundant granular eosinophilic cytoplasm and type B cells with a micro-vacuolar cytoplasm (HES x200)</p>
        </caption>
        <graphic xlink:href="PAMJ-19-294-g003"/>
      </fig>
      <fig id="F0004" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Immunohistochemical study shows a GCDFP-15 cytoplasmic expression in tumor cells</p>
        </caption>
        <graphic xlink:href="PAMJ-19-294-g004"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="S0003">
      <title>Discussion</title>
      <p>Apocrine carcinoma of the breast is a rare malignant tumor whose incidence varies between 0.3% and 4% of all female's breast cancer [<xref rid="CIT0001" ref-type="bibr">1</xref>]. This tumor is exceptional in men. Indeed, only a dozen cases have been described in the literature [<xref rid="CIT0002" ref-type="bibr">2</xref>]. Like our patient, the average age of onset is between the sixth and seventh decade [<xref rid="CIT0001" ref-type="bibr">1</xref>]. Its clinical mammographic and sonographic characteristics mimic those of non-apocrine breast invasive carcinoma. The cytology after fine needle aspiration may have a role in orienting. As in our patient, it shows apocrine cells with cell and nuclear atypias, a large irregular nucleus and a prominent nucleolus with abundant cytoplasm [<xref rid="CIT0003" ref-type="bibr">3</xref>]. Macroscopically, apocrine carcinoma is in the form of a nodule or endo-cystic growths, often multicentric [<xref rid="CIT0001" ref-type="bibr">1</xref>].</p>
      <p>Histologically, the tumor is defined as a carcinoma showing in more than 90% of tumor cells, cytological features of apocrine cells (mixture of varying proportions of type A cells and type B cells). Type A cells have abundant cytoplasm containing eosinophilic, PAS positive, diastase-resistant granular. This is due to an abundance of large mitochondria, some of which have abnormal peaks. Type B cells have a micro-vacuolar cytoplasm resembling foamy histiocytes or sebaceous cells. The tumor cells have visible cytoplasmic borders. Some apocrine carcinomas are exclusively composed of type A cells. In this case, the differential diagnosis is granular cell tumors. Other apocrine carcinomas are composed exclusively of type B cells. In this case, the differential diagnosis is histiocytic proliferation and inflammatory reactions. The distinction is made by immunohistochemical study showing positive staining of apocrine carcinoma by anti-cytokeratin antibodies [<xref rid="CIT0001" ref-type="bibr">1</xref>].</p>
      <p>Although apocrine carcinoma is a distinct histological entity, however, there is no sensitive and specific immunohistochemical marker for confirming apocrine differentiation. Immunohistochemical study shows an expression of GCDFP-15 in 76% to 100% of cases. The GCDFP-15 is a glycoprotein originally isolated from breast cyst fluid. It's localized in cytoplasmic vesicles, and in osmiophilic granules. With the development of this marker, a more objective diagnostic criterion has been introduced [<xref rid="CIT0004" ref-type="bibr">4</xref>]. Androgen receptors are expressed in 54% of cases [<xref rid="CIT0005" ref-type="bibr">5</xref>]. Moreover, tumor cells can express B72.3, estrogenic-beta receptors, HER2, p53 and Ki-67 [<xref rid="CIT0001" ref-type="bibr">1</xref>]. Usually, these tumors do not express the estrogen receptor-alpha, progesterone receptors and bcl-2. [<xref rid="CIT0001" ref-type="bibr">1</xref>] Concerning the molecular study, we note the presence of abnormalities in the long arm of chromosome 7 (genes encoding the GCDFP-15 and prolactin-inducible protein), also the loss of heterozygosity for the TP53 gene, the VHL gene (3p25), the NB gene (1p35-36), and PKD1/TSC2 gene (16p13) [<xref rid="CIT0006" ref-type="bibr">6</xref>]. The new molecular classification of breast cancers based on studies of CGH-array, classifies apocrine carcinoma individually [<xref rid="CIT0007" ref-type="bibr">7</xref>].</p>
      <p>Treatment protocols are similar to those of non-apocrine carcinoma. However, studies involving the use of anti-androgens are in progress [<xref rid="CIT0006" ref-type="bibr">6</xref>]. The survival rate at 5 years was significantly better for the apocrine carcinoma (72%) with a longer time to recurrence compared to non-apocrine carcinoma. Prognostic factors are essentially the mitotic account and TNM stage. [<xref rid="CIT0001" ref-type="bibr">1</xref>]</p>
    </sec>
    <sec sec-type="conclusion" id="S0004">
      <title>Conclusion</title>
      <p>Apocrine carcinoma of the breast is a distinct histological and molecular entity. It is rare in women and exceptional in man. Studies are being conducted to use anti-androgens such as targeted therapy.</p>
    </sec>
  </body>
  <back>
    <sec id="S0005">
      <title>Competing interests</title>
      <p>Authors declare no competing interests.</p>
    </sec>
    <sec id="S0006">
      <title>Authors&#x2019; contributions</title>
      <p>Authors contributed to the diagnosis of this tumor, revising critically the article for important intellectual content; and final approval of the version to be published.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Tavassoli</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Devilee</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ellis</surname>
            </name>
            <name>
              <surname>Schnitt</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Sastre-Garau</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Bussolati</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Eusebi</surname>
              <given-names>FAV</given-names>
            </name>
            <name>
              <surname>Peterse</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Mukai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tabar</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jacquemier</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Invasive breast carcinoma</article-title>
          <source>WHO Pathology and Genetics Tumours of the Breast and Female Genital Organs</source>
          <year>2003</year>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC Press</publisher-name>
          <fpage>36</fpage>
          <lpage>37, 56-59</lpage>
          <comment>World health organization</comment>
        </element-citation>
      </ref>
      <ref id="CIT0002">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shah</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Persaud</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Coard</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Apocrine carcinoma of the male breast</article-title>
          <source>West Indian Med J.</source>
          <year>1980</year>
          <month>12</month>
          <volume>29</volume>
          <issue>4</issue>
          <fpage>272</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">7467283</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0003">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>McHutchison</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Dowle</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>Fine Needle Aspiration Cytodiagnosis of Apocrine Carcinoma of the Breast</article-title>
          <source>Cytopathology.</source>
          <year>1992</year>
          <volume>3</volume>
          <issue>5</issue>
          <fpage>321</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">1288658</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0004">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Honma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Takubo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Akiyama</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sawabe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Arai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Younes</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kasumi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sakamoto</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast</article-title>
          <source>Histopathology.</source>
          <year>2005</year>
          <month>8</month>
          <volume>47</volume>
          <issue>2</issue>
          <fpage>195</fpage>
          <lpage>201</lpage>
          <pub-id pub-id-type="pmid">16045781</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0005">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bratthauer</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Lininger</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Man</surname>
              <given-names>YG</given-names>
            </name>
            <name>
              <surname>Tavassoli</surname>
              <given-names>FA</given-names>
            </name>
          </person-group>
          <article-title>Androgen and estrogen receptor mRNA status in apocrine carcinomas</article-title>
          <source>Diagn Mol Pathol.</source>
          <year>2002</year>
          <month>6</month>
          <volume>11</volume>
          <issue>2</issue>
          <fpage>113</fpage>
          <lpage>118</lpage>
          <pub-id pub-id-type="pmid">12045715</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0006">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Celis</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Cabez&#xF3;n</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Moreira</surname>
              <given-names>JM</given-names>
              <suffix>Gr</suffix>
            </name>
          </person-group>
          <article-title>Molecular characterization of apocrine carcinoma of the breast: Validation of an apocrine protein signature in a well-defined cohort</article-title>
          <source>Mol Oncol.</source>
          <year>2009</year>
          <month>6</month>
          <volume>3</volume>
          <issue>3</issue>
          <fpage>220</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="pmid">19393583</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0007">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weigelt</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Horlings</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Kreike</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Refinement of breast cancer classification by molecular characterization of histological special types</article-title>
          <source>Pathol.</source>
          <year>2008</year>
          <month>10</month>
          <volume>216</volume>
          <issue>2</issue>
          <fpage>141</fpage>
          <lpage>50</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
